mektovi
Generic: binimetinib
mektovi: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARRAY BIOPHARMA INC (ARRY) | Approved |
FDA Decisions
Approval(ARRY)
Frequently asked questions
Who is developing mektovi?
mektovi is being developed by ARRAY BIOPHARMA INC.
What is mektovi's latest FDA decision?
The most recent tracked FDA decision for mektovi is Approval, dated June 27, 2018.
Get deeper analysis on mektovi
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis